Michael Steiner - Dr Ing Member RD

DRPRF Stock  USD 59.39  4.01  6.32%   

Insider

Michael Steiner is Member RD of Dr Ing hc
Age 59
Phone49 711 911 0
Webhttps://www.porsche.com/international

Michael Steiner Latest Insider Activity

Tracking and analyzing the buying and selling activities of Michael Steiner against Dr Ing pink sheet is an integral part of due diligence when investing in Dr Ing. Michael Steiner insider activity provides valuable insight into whether Dr Ing is net buyers or sellers over its current business cycle. Note, Dr Ing insiders must abide by specific rules, including filing SEC forms every time they buy or sell Dr Ing'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Similar Executives

Showing other executives

INSIDER Age

Sabine KohleisenMercedes Benz Group AG
59
Kapila PerreraPorsche Automobil Holding
64
Oliver BlumeDr Ing hc
55
George WillsPorsche Automobil Holding
N/A
Lutz MeschkePorsche Automobil Holding
57
Albrecht ReimoldDr Ing hc
62
Andreas HaffnerDr Ing hc
58
Thomas LaubertMercedes Benz Group AG
50
Johannes LattweinPorsche Automobil Holding
N/A
Detlev PlatenDr Ing hc
59
Albrecht BamlerPorsche Automobil Holding
65
Jens BruckerPorsche Automobil Holding
N/A
Harald WilhelmMercedes Benz Group AG
57
Manfred DossPorsche Automobil Holding
65
Jorg BurzerMercedes Benz Group AG
53
Wolfgang LeimgruberPorsche Automobil Holding
N/A
Lutz MeschkeDr Ing hc
57
Steffen HoffmannMercedes Benz Group AG
53
Hans MScPorsche Automobil Holding
72
Hubertus TroskaMercedes Benz Group AG
63
Hannes RuoffPorsche Automobil Holding
N/A
Porsche AG engages in automotive and financial services businesses. Porsche AG operates as a subsidiary of Porsche Holding Stuttgart GmbH. Dr ING is traded on OTC Exchange in the United States. Dr Ing hc [DRPRF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Dr Ing hc Leadership Team

Elected by the shareholders, the Dr Ing's board of directors comprises two types of representatives: Dr Ing inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DRPRF. The board's role is to monitor Dr Ing's management team and ensure that shareholders' interests are well served. Dr Ing's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dr Ing's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lutz Meschke, CFO Board
Michael Steiner, Member RD
Albrecht Reimold, Member Logistics
Detlev Platen, Head Board
Barbara Frenkel, Member Procurement
Andreas Haffner, Member Affairs
Oliver Blume, Chairman CEO

DRPRF Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Dr Ing a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in DRPRF Pink Sheet

Dr Ing financial ratios help investors to determine whether DRPRF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DRPRF with respect to the benefits of owning Dr Ing security.